Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Clodronic acid
Drug ID BADD_D00494
Description Clodronic acid is a first generation bisphosphonate similar to [etidronic acid] and [tiludronic acid].[A203111] These drugs were developed to mimic the action of pyrophosphate, a regulator of calcification and decalcification.[A1923] clodronate’s use has decreased over the years in favor of the third generation, nitrogen containing bisphosphonate [zoledronic acid], [ibandronic acid], [minodronic acid], and [risedronic acid].[A203111] Clodronic acid is not FDA approved, but is approved in Canada.[L13910]
Indications and Usage Clodronic acid is indicated as an adjunct in the management of osteolysis from bone metastases of malignant tumors and for management of hypercalcemia of malignancy.[L13910]
Marketing Status approved; investigational; vet_approved
ATC Code M05BA02
DrugBank ID DB00720
KEGG ID D03545
MeSH ID D004002
PubChem ID 25419
TTD Drug ID D00HNB
NDC Product Code Not Available
UNII 0813BZ6866
Synonyms Clodronic Acid | Acid, Clodronic | Dichloromethane Diphosphonate | Diphosphonate, Dichloromethane | Dichloromethylenebisphosphonate | Dichloromethanediphosphonic Acid | Acid, Dichloromethanediphosphonic | Dichloromethylene Biphosphonate | Biphosphonate, Dichloromethylene | Dichloromethylene Diphosphonate | Diphosphonate, Dichloromethylene | Cl2MDP | Dichloromethanediphosphonate | Clodronate | Clodronate Disodium | Disodium, Clodronate | Clodronate Sodium | Sodium, Clodronate | Bonefos
Chemical Information
Molecular Formula CH4Cl2O6P2
CAS Registry Number 10596-23-3
SMILES C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Nausea07.01.07.001--
Neoplasm malignant16.16.01.001--Not Available
Nephrocalcinosis20.04.01.001--Not Available
Oliguria20.01.03.004--Not Available
Pharyngitis11.01.13.003; 07.05.07.004; 22.07.03.004--
Pneumonia22.07.01.003; 11.01.09.003--Not Available
Proteinuria20.02.01.011--
Pruritus23.03.12.001--
Rash23.03.13.001--Not Available
Renal failure20.01.03.005--Not Available
Skin disorder23.03.03.007--Not Available
Type I hypersensitivity10.01.03.006--Not Available
Urethral disorder20.07.01.002--Not Available
Urinary tract disorder20.08.01.001--Not Available
Urticaria10.01.06.001; 23.04.02.001--
Vomiting07.01.07.003--
Wheezing22.03.01.009--
Foetor hepaticus07.01.06.026; 09.01.05.006--Not Available
Protein urine present13.13.02.006--Not Available
Hepatic cancer metastatic16.07.02.002; 09.04.02.006--Not Available
Connective tissue disorder10.04.04.026; 15.06.01.006--Not Available
Mediastinal disorder22.09.03.001--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
Renal impairment20.01.03.010--Not Available
Osteonecrosis of jaw24.04.05.005; 15.02.04.010--
Oral disorder07.05.01.005--Not Available
Acute kidney injury20.01.03.016--
The 2th Page    First    Pre   2    Total 2 Pages